Certified by Founder Lodge
Hemab Therapeutics
Denmark - Copenhagen, Capital Region
START UP
1 Disclosed Funding Rounds $135,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Hemab Therapeutics ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhag
Date | Round | Raised | Participating Investors |
---|---|---|---|
February, 22 ,2023 | Series B | $135,000,000 |